The merger operation consists of the acquisition, by Siemens Healthineers AG (“SHS”), of the European business of manufacturing imaging products using radioligands from the Novartis Group, comprising the acquisition of all shares in several companies held by Advanced Accelerator Applications , SA (“Adacap”), including, in Portugal, the company Advanced Accelerator Applications Portugal Unipessoal Lda. ("Adacap Portugal").